Rigaku Corporation, a Rigaku Holdings Group company opened Rigaku BioScience Lab in Cambridge. Rigaku has begun operation of MoleQlyze at the Rigaku BioScience Lab. MoleQlyze incorporates a technology, developed by Rigaku, called electron density topography (EDT), which elucidates the shapes and dynamic characteristics of biological macromolecules, including antibodies, protein complexes, and virus particles, in solution. Rigaku has begun accepting inquiries for technology demonstrations and analysis under contract.
Location of the Rigaku BioScience Lab
SmartLabs, 21 Erie St, Cambridge, MA 02139, USA
Explore More About EDT and MoleQlyze
Introduction to the Products and Technology: https://edt.rigaku.com
Press Release on EDT: https://rigaku-holdings.com/english/news/edt/
Press Release on Rigaku BioScience Lab: https://rigaku-holdings.com/english/news/press-release-rigaku-bioscience-lab-opens-in-usa-to-provide-new-visualization-technologies-for-biopharmaceuticals-at-the-worlds-largest-bio-science-research-hub/
Featured in Nature Research Custom Media: https://www.nature.com/articles/d42473-024-00201-4
If you are interested in the Rigaku BioScience Lab and MoleQlyze, please feel free to contact us at edt@rigaku.com.